Related Experiment Video

Updated: Aug 14, 2026

RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes
09:19

RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes

Published on: July 22, 2014

Ribozyme mimics as catalytic antisense reagents

J K Bashkin1, U Sampath, E Frolova

  • 1Department of Chemistry, Washington University, St. Louis, MO 63130-4899, USA.

Applied Biochemistry and Biotechnology
|July 1, 1995
PubMed

Insights

Researchers developed a novel chemical method to destroy specific messenger RNA (mRNA) sequences, offering a potential new strategy for antiviral and anticancer therapies with fewer side effects.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Diseases like viral/fungal infections and cancers can stem from specific unwanted protein expression, potentially classified as induced genetic disorders.
  • Developing targeted therapies to inactivate disease-causing genes based on nucleic acid sequences is crucial for effective treatment with reduced side effects.

Purpose of the Study:

  • To develop a chemical approach for gene-specific pharmaceutical agents capable of catalytically destroying target mRNA sequences.
  • To create functional ribozyme mimics using small-molecule catalysts and oligonucleotide probes for sequence specificity.

Main Methods:

  • Utilized hydrolysis as a chemical destruction method due to its compatibility with living cells.
  • Designed sequence-specific catalytic RNA hydrolysis reagents, termed ribozyme mimics.
  • Employed a terpyridylCu(II) complex for catalytic cleavage activity and an oligonucleotide for sequence specificity.

Main Results:

  • Successfully demonstrated sequence-specific, hydrolytic cleavage of mRNA from the HIV gag gene using the developed ribozyme mimic.
  • The reagent effectively combined catalytic activity with precise sequence targeting.

Conclusions:

  • The developed ribozyme mimic represents a promising chemical strategy for sequence-specific mRNA degradation.
  • This approach holds potential for creating novel antiviral and anticancer agents with enhanced specificity and reduced side effects.

More Related Videos

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction03:38

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...